Health TrialsbyHealthPanel

Parents' HPV Stories

ConditionHPV Vaccination
Trial statusNot yet recruiting
Trial phaseNot applicable
Trial typeInterventional
Biological sexFemale
Age18+
SponsorAnne E Ray

About this trial

The goal of this clinical trial is to evaluate the feasibility of intervention implementation in two clinics in rural KY, and its preliminary efficacy with regards to increasing vaccine confidence in a sample of vaccine hesitant parents.

Hypothesis: Parents will report increased vaccine confidence scores post-intervention.

Data from this study will provide preliminary data for a larger scale evaluation of the intervention.

Participants will be asked to complete surveys, view a web-based intervention and then visit with their child's healthcare provider.

Eligibility criteria

This trial accepts healthy volunteers

Qualifiers

status as a mother or female guardian of an 11-17-year-old adolescent

status as a U.S. resident

self-reported ability to read English

self-reported HPV vaccine hesitant using established methodology

Disqualifiers

None

Trial design

Design model

Single group

Treatments tested in this trial

  • Web Application

    Behavioral

    A web application for vaccine-hesitant parents and their teens with brief, 90-second narrative videos and tailored, motivational content

  • Provider Elaborated Prompts

    Behavioral

    A component for providers that suggests elaborated prompts to be used with parents that align with the content of the web application, are tailored to parent concerns, and are motivational in nature

Treatment groups

58 Participants
are divided into 1 treatment group
Group A: Parents' Stories Web Application + Provider Elaborated PromptsExperimental treatment 2 interventions

Trial outcomes

Primary outcomes

1

Change in HPV Vaccine Hesitancy Scale score

9-item scale from Strongly Disagree (1) to Strongly Agree (5); scores range from 1-5, with higher scores indicating greater hesitancy

Time frame
From pretest to posttest (up to two weeks)
2

Change Human Papillomavirus Knowledge Questionnaire score

13-item scale with True / False / I don't know response options; scores range from 0-13 with higher scores indicating greater vaccine knowledge

Time frame
From pretest to posttest (up to two weeks)
3

Change in intent to discuss HPV vaccine with provider

Answers include Very likely; Somewhat likely; Not too likely; Not likely at all; Not sure / do not know

Time frame
From pretest to posttest (up to two weeks)
4

Change in HPV vaccine intent

1 item adapted from NIS-TEEN survey. Answers include very likely; somewhat likely; not too likely; not likely at all; not sure / do not know

Time frame
From pretest to posttest (up to two weeks)

Secondary outcomes

Other outcomes

Sponsors and contacts

Click on the lead sponsor to view all of their trials.

Anne E Ray

Lead sponsor

University of Kentucky

Sponsor institution

Real Prevention, LLC

Collaborator

Merck Institute for Therapeutic Research

Collaborator

Source ClinicalTrials.gov

This trial is not recruiting at the moment. You can still explore other options: